pSivida Corp.
(NASDAQ : PSDV)

( )
PSDV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading PSDV News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.16%70.550.9%$746.71m
AMGNAmgen Inc.
0.00%170.851.1%$707.06m
CELGCelgene Corporation
0.00%130.931.1%$645.79m
REGNRegeneron Pharmaceuticals, Inc.
0.00%502.122.7%$590.62m
BIIBBiogen Inc.
0.00%271.251.2%$491.73m
ALXNAlexion Pharmaceuticals, Inc.
-1.24%120.601.9%$445.24m
VRTXVertex Pharmaceuticals Incorporated
0.00%129.231.9%$271.19m
INCYIncyte Corporation
0.00%130.312.6%$256.98m
CLVSClovis Oncology, Inc.
0.00%89.9618.0%$244.46m
TSROTESARO, Inc.
0.00%141.0314.7%$243.48m
BLUEBluebird Bio, Inc.
0.37%107.3019.3%$160.58m
ILMNIllumina, Inc.
0.00%176.363.5%$150.43m
KITEKite Pharma, Inc.
0.00%98.0516.1%$139.68m
EXASExact Sciences Corporation
0.00%34.0926.3%$128.59m
AAgilent Technologies, Inc.
0.00%58.871.5%$122.37m

Company Profile

pSivida Corp. develops tiny, sustained-release products, which are designed to deliver drugs and biologics at a controlled and steady rate for weeks, months or years. The company through its technology platforms Duraser and Tethadur is focused on treatment of chronic diseases of the back of the eye and are also exploring applications outside ophthalmology. It is also developing a bioerodible, injectable micro-insert delivering latanoprost to treat glaucoma and ocular hypertension. pSivida was founded by Roger Aston in March 2008 and is headquartered in Waterson, MA.,05TJPZ-E